Client News

Roquefort Therapeutics plc: Publication of New Research
Home / Client News / Roquefort Therapeutics plc: Publication of New Research

Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, is pleased to inform shareholders that a new research note on the Company has recently been published by Pitt Street Research.

The research can be found on the Company’s website via the link below:


If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This